Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 35c; offers guidance
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q3 EPS of $0.68, $0.35 better than the analyst estimate of $0.33. Revenue for the quarter came in at $148.4 million versus the consensus estimate of $136.37 million.
GUIDANCE:
Catalyst Pharmaceuticals sees FY2025 revenue of $565-585 million, versus the consensus of $562.1 million.
For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
